As a key regulator in the metabolism of glucose, cholesterol, lipid, and carbohydrate, the first evidence suggestive of LXR involvement in cancer came from studies demonstrating upregulation of LXR target gene sterol response element‐binding protein 1c (SREBP1c) in prostate cancer [30, 31]. Here, SREBF1 is linked to prostate carcinoma.